Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

5.460 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 50,673
Open 5.460
Bid (Size) 5.550 (1)
Ask (Size) 5.560 (6)
Prev. Close 5.460
Today's Range 5.460 - 5.460
52wk Range 5.300 - 18.55
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Could a Short Squeeze Be Coming for These 3 Heavily Shorted Stocks?
Should investors expect any of these stocks to turn their fortunes around next year? 
Via The Motley Fool
Where Will Novavax Be in 3 Years?
Novavax shares have plunged from early pandemic highs. 
Via The Motley Fool

Performance

YTD
-44.23%
-44.23%
1 Month
-16.26%
-16.26%
3 Month
-34.61%
-34.61%
6 Month
-26.51%
-26.51%
1 Year
-67.19%
-67.19%

More News

Read More
Novavax Prepares Further Cost Cuts To Better Align With Demand-Challenged COVID-19 Vaccine Market
Via Benzinga
Exposures COVID-19
Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell's Speech
Via Benzinga
Novavax's Earnings: A Preview
Via Benzinga
The Fall Vaccination Season Is Here. Is Novavax a Buy?
Via The Motley Fool
Down 75% From Its High, Has Novavax Stock Become Too Cheap to Pass Up?
Via The Motley Fool
Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares
Via Investor's Business Daily
7 Dangerous Stocks to Avoid No Matter What
Via InvestorPlace
Top 6 Nasdaq Short Squeeze Play Stocks
Via Talk Markets
Pfizer Reportedly Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Do These 5 Words From Pfizer Mean Trouble for Novavax?
Via The Motley Fool
Exposures COVID-19
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories
Via Benzinga
Topics ETFs
Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion
Via Investor's Business Daily
Exposures COVID-19
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine
Via Benzinga
Exposures COVID-19
The 10 Most Shorted Stocks Include 3 Tesla Rivals, But Not TSLA
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year
Via Benzinga
BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Is Novavax Stock a Buy Now?
Via The Motley Fool
Novavax (NVAX) Stock Slides Despite Vaccine Availability
Via InvestorPlace
AZZ, VOXX International And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?
Via The Motley Fool
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.